Effect of ursodeoxycholic acid on autoimmune-associated chronic hepatitis C. (Q53345638)

13 May 2018

title

Effect of ursodeoxycholic acid on autoimmune-associated chronic hepatitis C. (English)

1 reference

13 May 2018

author name string

Nakamura K

1

1 reference

13 May 2018

Yoneda M

2

1 reference

13 May 2018

Takamoto S

3

1 reference

13 May 2018

Nakade Y

4

1 reference

13 May 2018

Yokohama S

5

1 reference

13 May 2018

Tamori K

6

1 reference

13 May 2018

Aso K

7

1 reference

13 May 2018

Matui T

8

1 reference

13 May 2018

Sato Y

9

1 reference

13 May 2018

Aoshima M

10

1 reference

13 May 2018

Makino I

11

1 reference

13 May 2018

publication date

1 May 1999

1 reference

13 May 2018

Journal of Gastroenterology and Hepatology

published in

1 reference

13 May 2018

volume

14

1 reference

13 May 2018

issue

5

1 reference

13 May 2018

page(s)

413-418

1 reference

13 May 2018

Autoimmunity and hepatotropic viruses

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.1999.01898.X

Immunologic features and HLA associations in chronic viral hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.1999.01898.X

Hepatitis C virus infection can mimic type 1 (antinuclear antibody positive) autoimmune chronic active hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.1999.01898.X

The international autoimmune hepatitis score in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.1999.01898.X

Ursodiol for the long-term treatment of primary biliary cirrhosis. The UDCA-PBC Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.1999.01898.X

Microdroplet testing for HLA-A, -B, -C, and -D antigens. The Phillip Levine Award Lecture

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.1999.01898.X

Efficacy of ursodeoxycholic acid therapy in chronic viral hepatitis C with high serum gamma-glutamyltranspeptidase levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.1999.01898.X

Present status of autoimmune hepatitis in Japan--correlating the characteristics with international criteria in an area with a high rate of HCV infection. Japanese National Study Group of Autoimmune Hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.1999.01898.X

Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.1999.01898.X

Interferon and prednisone therapy in chronic hepatitis C with non-organ-specific antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.1999.01898.X

Efficacy of ursodeoxycholic acid in the treatment of patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.1999.01898.X

Predictors of the efficacy of interferon therapy in chronic hepatitis C virus infection. Tokyo-Chiba Hepatitis Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.1999.01898.X

10.1046/J.1440-1746.1999.01898.X

21 January 2018

Identifiers

DOI

1 reference

13 May 2018

1 reference

13 May 2018